Publications and Digital Products

This report presents data from DAWN using national estimates and trends of opioid-involved emergency department (ED) visits in the United States, including those involving prescription opioids, fentanyl, heroin, and opioids not otherwise specified.

The STOP Act requires an annual report on each State's performance in enacting, enforcing, and creating laws, regulations, and programs to prevent or reduce underage drinking. 

This State Report primarily includes data from calendar year 2022 and 2023. Regional and state profile data were drawn from the most recently available federal survey data as of 2022. State legal data reflect the status of the law as of January 1, 2023. State survey data, collected in 2023, were drawn from the most recent 12-month period in which the states maintained the data.

SAMHSA has issued two new papers on integration of behavioral health care in specialty care settings such as oncology and gastroenterology clinics. One paper focuses on care for adults and the other pediatric populations. The two papers discuss examples of integrated care models, key components of integrated care models and examples. The goal of these papers is to help ensure patients in these specialty care settings have access to behavioral health care.

The 2024 Report to Congress on the Prevention and Reduction of Underage Drinking includes national data on underage drinking patterns, the federally coordinated approach on underage drinking prevention and treatment, and information on the National Media Campaign: "Talk. They Hear You."®

This report provides guidance to decision-makers about how to identify and select the intervention(s) that will best serve their state or community, as required by the STOP Act.1 The STOP Act also requires the Interagency Coordinating Committee on the Prevention of Underage Drinking (ICCPUD) to include in the report measures of states’ use of best practices in preventing and reducing underage drinking.

The Behavioral Health Care Access Among Lesbian, Gay, and Bisexual (LGB) Populations report highlights findings from the 2023 SAMHSA publication Lesbian, Gay, and Bisexual Behavioral Health: Results from the 2021 and 2022 National Surveys on Drug Use and Health on the elevated rates of substance use, suicidality, and mental illness among LGB individuals compared to straight individuals. The report investigates whether these findings remain statistically significant when controlling for factors such as age, race, educational attainment, marital status, and financial hardship.

The Drug Abuse Warning Network (DAWN) National Estimates from Drug-Related Emergency Department Visits, 2023 report provides weighted national estimates. The frequency of substance-related visits increased by 5.8 percent compared to estimates in 2022. Rates of all substance-related ED visits from participating hospitals were highest among individuals with the following characteristics: males (2,668 per 100,000), individuals who were not Hispanic or Latino (2,391 per 100,000), and Black individuals, after accounting for the underlying population (4,053 per 100,000 versus 1,736 per 100,000 in the next highest subpopulation). The top substances reported were alcohol, cannabis, opioids, methamphetamines, cocaine, and benzodiazepines.